Spero Therapeutics (SPRO) Earnings Analysis
Spero Therapeutics (SPRO) next reports earnings on 2026-08-11, consensus EPS -0.17 USD. Last quarter (2026-03-26) it beat with EPS 0.53 USD vs -0.2 USD est (+365%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E 4.71.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SPRO next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.17 USD |
| Revenue estimate | 0.00B |
SPRO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | 0.53 USD | -0.2 USD | +365% | Beat |
| 2025-11-13 | -0.13 USD | -0.25 USD | +48% | Beat |
| 2024-11-14 | -0.32 USD | -0.27 USD | -18.5% | Miss |
| 2024-08-05 | -0.33 USD | -0.35 USD | +5.7% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
SPRO valuation and analyst view
| Trailing P/E | 4.71 |
|---|---|
| Trailing EPS | 0.26597 USD |
| Price / book | 1.37 |
| Dividend yield | 0.00% |
| Market cap | 0.08B |
| Analyst consensus | Buy (6 buy / 5 hold / 2 sell) |
Related research pages
Frequently asked questions
When is Spero Therapeutics (SPRO)'s next earnings date?
Spero Therapeutics is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.17 USD and revenue estimate of 0.00B.
Did SPRO beat earnings last quarter?
In its 2026-03-26 report, SPRO posted EPS of 0.53 USD versus a -0.2 USD estimate — a beat of 365%.
What is SPRO's earnings track record?
Over the last 4 reported quarters with consensus data, SPRO beat estimates 3 times (75%).
What is SPRO's current P/E ratio and EPS?
SPRO trades at a trailing P/E of 4.71 on trailing EPS of 0.2659668720672286 USD.
What do analysts rate SPRO?
Analyst consensus is "Buy" across 13 ratings (0 strong buy, 6 buy, 5 hold, 2 sell, 0 strong sell).